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Introduction: Studies have shown progressive cerebral damage in patients with refractory mesial 
temporal lobe epilepsy (MTLE). However, this has not been demonstrated in benign forms of 
MTLE such as familial mesial temporal lobe epilepsy (FMTLE). Purpose: To evaluate progression 
of hippocampal atrophy (HA) in patients with sporadic mesial temporal lobe epilepsy (SMTLE) and 
FMTLE by longitudinal Magnetic resonance images (MRIs) acquired with at least 7 months of 
interval. Method: We included 35 patients with FMTLE (25 classified as benign and 10 refractory) 
and 33 with SMTLE (4 benign and 29 refractory). All MRIs were analyzed by an investigator blind for 
clinical data. Hippocampal analyses were performed manually in coronal 3 mm thick T1 inversion 
recovery, using the software Scion Image®. Volumes were compared to those from a control group, 
and HA was determined for volumes below two standard deviations from the mean of controls. 
Results: The mean interval between the first (MRI1) and second MRI (MRI2) was 90 months for 
FMTLE and 45 months for SMTLE group. FMTLE group: volumetry demonstrated HA in 20 patients 
in MRI1 and in 23 patients in MRI2. There was significant progression of HA in FMTLE patients 
between MRIs in both benign and refractory FMTLE patients (benign FMTLE: right hippocampus, 
p = 0.001 and left hippocampus, p < 0.001; refractory FMTLE: right hippocampus, p = 0.022 and left 
hippocampus, p < 0.010). SMTLE group: volumetry demonstrated HA in 27 patients in MRI1 and in 
29 patients in MRI2. In the group analysis, there was a significant reduction of the right (p < 0.0001) 
and left (p < 0.0001) hippocampal volumes during the follow-up period. Although the mean time 
between the MRIs in the FMTLE group was twice the time of the SMTLE group, the progression 
of volume loss was similar in both groups, indicating a slower progression in the FMTLE patients. 
Conclusion: FMTLE patients have progressive hippocampal volume reduction independently of 
seizure frequency although the progression of HA seems to be slower than in SMTLE.
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The objective of this study was to investigate MRI volumetric 
abnormalities of hippocampus of patients with FMTLE and evalu-
ate the possibility of progression of these abnormalities in patients 
with FMTLE and sporadic mesial temporal lobe epilepsy (SMTLE) 
in a longitudinal study with a prolonged follow-up.
Materials and Methods
Patients from our epilepsy clinic with clinical and electroencepha-
lographic diagnosis of MTLE and at least two MRIs obtained from 
October 1998 and January 2008 were followed prospectively and 
were included in this study.
All patients were interviewed in appointments every 3–6 months 
during the follow-up-period and seizure characteristics were constantly 
accessed. Patients were only included if they had seizures with typical 
mesial temporal lobe semiology and no atypical findings on the EEG.
According to clinical characteristics, patients were divided in two 
subgroups: (1) FMTLE (patients with at least two first or second 
degree relatives with MTLE as defined previously Kobayashi et al., 
2001) and (2) SFMTLE (patients with no family recurrence).
introduction
Mesial temporal lobe epilepsy (MTLE) is the most common type 
of partial epilepsy, and it is frequently associated with hippocampal 
sclerosis (HS; Gastaut et al., 1975; Bruton, 1988). Magnetic reso-
nance images (MRI) signs of HS include hippocampal atrophy (HA), 
abnormal shape, loss of internal structure, and T2 hyperintense signal 
(Cascino et al., 1991; Cendes et al., 1993; Jackson et al., 1993).
The familial form of mesial temporal lobe epilepsy (FMTLE) was 
first described as a benign form of partial epilepsy (Berkovic et al., 
1996; Kobayashi et al., 2001). Previous studies have demonstrated 
the presence of MRI signs of HS among patients with FMTLE and in 
some asymptomatic relatives (Kobayashi et al., 2001, 2002, 2003).
Clinical and experimental studies have tried to demonstrate 
the progression of hippocampal damage in patients with epilepsy 
and its association with refractory seizures with discrepant results 
(Kalviainen et al., 1998; Briellmann et al., 2002; Fuerst et al., 2003; 
Cendes, 2005; Cendes et al., 2005). However, there are no previ-
ous studies trying to demonstrate this association in patients 
with FMTLE.
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There was no difference of sex distribution or age between FMTLE 
and SMTLE individuals or between patients and controls.
VoluMetric study
Familial mesial temporal lobe epilepsy
Volumetric study demonstrated HA in 20 (57%) patients (6 right, 
9 left, 5 bilateral) in MRI1 and in 23 (66%) patients (7 right, 11 
left, 5 bilateral) in MRI2. Group analysis demonstrated a signifi-
cant difference between the volumes of patients and controls for 
both the first and second MRI (t-test, MR1: right hippocampus, 
p = 0.002; left hippocampus, p = 0.003; AI, p = 0.017. MR2: right 
hippocampus, p < 0.001; left hippocampus, p < 0.001; AI, p = 0.010; 
Figure 1).
There was significant hippocampal volume reduction in the 
MRI2 when compared to MRI1 (paired t-test right hippocampus, 
p < 0.001; left hippocampus, p < 0.001; Figure 2).
When we divided the FMTLE patients in benign (25 (71%) 
individuals) and refractory (10 individuals), it was still possible 
to observe significant hippocampal volume reduction in the MRI2 
when compared to MRI1 in both groups (paired t-test, benign 
FMTLE: right hippocampus, p = 0.001 and left hippocampus, 
p < 0.001; refractory FMTLE: right hippocampus, p = 0.022 and 
left hippocampus, p < 0.010). In the group of benign FMTLE, 
14 patients (56%) had HA in MR1 and 16 (64%) in MRI2 
and in the refractory group 6 (60%) had HA in MRI1 and 7 
(70%; Figure 3).
Sporadic mesial temporal lobe epilepsy
Twenty-seven patients (82%) had HA in the MRI1. Two patients 
with normal first MRI presented HA at the second scan (29/33 
patients, 88%). Group analysis demonstrated a significant dif-
ference between the volumes of patients and controls for both 
the first and second MRI (t-test MR1: right hippocampus, 
p = 0.02; left hippocampus, p < 0.000; AI, p < 0.0001. MR2: 
right hippocampus, p = 0.004; left hippocampus, p < 0.001; AI, 
p < 0.001; Figure 1).
Control group was composed of 14 health individuals, with no 
familial history of epilepsy and with two MRI performed with a 
minimum interval of 7 months.
Patients were also classified as benign or refractory based on the 
number of seizures presented on the year before the first MRI and 
in between the acquisition of both MRIs. Patients who had seizure 
remission, were seizure-free under AED or had sporadic seizures 
(three or less complex partial seizures per year) or had only simple 
partial seizures (typical MTLE auras) were considered as benign 
(for more detail, see Kobayashi et al., 2001).
Each patient had at least three routine EEG recordings with 30 min 
duration each, using the 10–20 electrode placement with additional 
temporal (T1, T2, and zygomatic electrodes) in an 18 or 32-channel 
digital EEG recording system, except for four patients with FMTLE 
who were under remission and refused to have  follow-up EEGs. 
All patients with refractory seizures had abnormal EEG, show-
ing epileptiform discharges over the anterior-mid temporal lobe 
region(s) coincident with the side of MRI showing signs of HS. In 
the FMTLE group, five patients who were under remission and one 
with rare seizures had normal routine EEGs (Kobayashi et al., 2001). 
The remaining FMTLE patients had abnormal EEG in one or both 
anterior-mid temporal lobe regions. All patients had typical history 
and semiology of mesial TLE (Cendes et al., 2005).
All patients signed an informed consent approved by the Ethic 
Committee of our institution before each MRI. Clinical data were 
collected prospectively. MRIs were performed in a 2T-scanner, with 
T1 and T2 acquisitions in three orthogonal planes. We used 3 mm 
T1-“inversion recovery” (T1-IR) coronal slices (flip angle = 200°; 
TR = 2800, TE = 14, inversion time = 840, matrix 130 × 256, 
FOV = 16 cm × 18 cm) for volumetric analysis.
Hippocampal volumes were determined manually (Watson et al., 
1997) in the 3-mm T1-IR coronal images using Scion Image® soft-
ware. The investigator who performed the volumetric and signal 
evaluation was blinded about patients’ clinical data at the moment of 
MRI study. Hippocampal volumes were corrected by total intracranial 
volume for each patient to eliminate variation of the size of the brain 
(Watson et al., 1997). HA was determined for either total volumes or 
asymmetry index (smaller/larger ratio) below two standard devia-
tions from the mean of the control group (Z-score < or = −2).
Statistical analysis was obtained with Systat 9® software. Chi-
square test was used to determined differences of frequencies and 
paired t-test was used to compare the results between MRI1 and 
MRI2. The statistical significance was set to p < 0.05.
results
deMographic aspects
Familial mesial temporal lobe epilepsy
Thirty-five patients with FMTLE were included (9 men; mean age 
41 years, minimum 17, and maximum 71). The mean interval between 
MRI1 and MRI2 was 90 months (ranging from 20 to 121 months). 
Twenty-five patients (71%) were classified as benign.
Sporadic mesial temporal lobe epilepsy
Thirty-three patients were included (14 men; mean age 36 years 
range from 21 to 70). The mean interval between MRI1 and MRI2 
was 45 months (range from 7 to 85 months). Only four patients 
(12%) were classified as benign.
FIguRe 1 | group analysis demonstrated significant difference of 
hippocampal volumes of controls and patients (FMTLe and SMTLe) for 
both the first and second MRI. Lhip1, left hippocampus in the first MRI; 
Lhip2, left hippocampus in the second MRI; Rhip1, right hippocampus in the 
first MRI; Rhip2, right hippocampus in the second MRI.
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discussion
As demonstrated by previous studies, we observed that FMTLE 
patients commonly have HA detected by post-processing MRI 
techniques (57–66%; Kobayashi et al., 2001, 2003), although this is 
less frequent than observed in SMTLE (82–88%; Watson et al., 1997; 
Fuerst et al., 2003; Cendes et al., 2005). What we were able to dem-
onstrate for the first time is that, like in SMTLE (Watson et al., 1997; 
Pitkänen et al., 2002; Cendes, 2005; Bonilha et al., 2006; Bernhardt 
et al., 2009; Coan et al., 2009), FMTLE patients have hippocampal 
volume reduction over time, independently of seizure frequency.
Familial mesial temporal lobe epilepsy is considered a benign 
form of epilepsy, although some patients present with medically 
refractory seizures and require surgical treatment (Berkovic et al., 
1996; Kobayashi et al., 2001, 2002, 2003). In the present study 
the majority of patients had a benign form of FMTLE (71%) as 
expected, while the majority of SMTLE individuals were refrac-
tory (88%). Previous clinical (Cendes, 2005; Bonilha et al., 2006; 
Coan et al., 2009) and experimental (Bonilha et al., 2006) studies 
of refractory MTLE have shown progressive atrophy of mesial tem-
poral lobe structures and also of neocortical structures (Bonilha 
et al., 2006; Bernhardt et al., 2009; Coan et al., 2009) over time and 
some also correlated the seizure frequency with the progression 
of damage (Kalviainen et al., 1998; Briellmann et al., 2002; Fuerst 
et al., 2003; Cendes, 2005; Cendes et al., 2005). However, there are 
no studies showing unequivocal evidence of progressive damage in 
patients with benign forms of epilepsy, such as FMTLE.
We made an option, in this study, to consider as benign those 
patients with up to three complex partial seizures per year or 
only simple partial seizures, although this definition is subjec-
tive (Kobayashi et al., 2001). However, for better understanding 
of MTLE some classification must be used to try to clarify these 
gaps (Labate et al., 2011). We hypothesized that seizure frequency 
has influence on the evolution of the disease, as demonstrated by 
previous clinical, experimental, neuroimaging, and neuropsycho-
logical studies (Kalviainen et al., 1998; Pitkänen et al., 2002; Fuerst 
et al., 2003; Cendes, 2005; Bonilha et al., 2006; Bernhardt et al., 
2009; Coan et al., 2009). Although our classification is arbitrary, 
Paired t-test comparing MRI1 and MRI2 showed a significant 
reduction of the right (p = 0.009) and left (p = 0.0025) hippocampal 
volumes during the follow-up period (Figure 2).
We also subdivided the SMTLE patients in benign [4 (12%) 
individuals; 2 (50%) with HA in MR1 and 3 (75%) with HA in 
MRI2] and refractory [29 individuals; 25 (86%) with HA in MR1 
and 26 (90%) with HA in MRI2]. However, the number of patients 
in the benign group was too small for statistical analysis.
Although the mean time between the MRIs in the FMTLE group 
was twice the time of the SMTLE group, there was no difference 
of degree of volume reduction in MRI2 among the two groups 
(FMTLE or SMTLE; t-test, right hippocampus: p = 0.886, and left 
hippocampus: p = 0.598).
Control group
Paired t-test comparing MRI1 and MRI2 failed to demonstrate a 
significant reduction of the right (p = 0.259) or left (p = 0.888) 
hippocampal volumes during the follow-up period in the control 
group (Figure 1).
FIguRe 2 | Box and whisker plots: the bottom and top of the box represents 
the 25th and 75th percentile (the lower and upper quartiles, respectively), 
and the band near the middle of the box is the 50th percentile (the median). 
The “*” means outliers. Paired t-test comparing MRI1 and MRI2 showed a 
significant reduction of the right and left hippocampal volumes during the 
follow-up period in FMTLE and SMTLE groups. Lhip1, left hippocampus in the 
first MRI; Lhip2, left hippocampus in the second MRI; Rhip1, right hippocampus 
in the first MRI; Rhip2, right hippocampus in the second MRI.
FIguRe 3 | example of MRI acquired at time zero (MRI 1) and after 
20 months (MRI 2), in a patient with FMTLe. Hippocampal volumetry 
demonstrated left hippocampal atrophy at MRI 1 (left Z-score = −2.33) and 
bilateral hippocampal atrophy at MRI 2 (left Z-score = −3.63 and right 
Z-score = −2.81), indicating progression of left hippocampal atrophy and the 
development of right hippocampal atrophy overtime. R, right side; L, left side.
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majority of FMTLE individuals were benign, they could have a 
second MRI after a longer interval. Additionally, we had the prior 
hypothesis that the FMTLE patients would have no or very mild 
progression, since most of them had a “benign” clinical course 
(remission, seizure control, or rare seizures). If they had two MRIs 
with a short interval and we did not find a significant hippocampal 
volume difference we would be left with the question that it could 
have been due to the short interval or low seizure frequency in 
this group.
The fact that seizures are responsible for additional damage in 
patients with epilepsy is controversial (Cendes, 2005). While some 
neuroimaging studies describe a significant relation of seizure fre-
quency and cerebral volume reduction of patients with refractory 
epilepsy (Bonilha et al., 2006; Bernhardt et al., 2009; Coan et al., 
2009), other studies did not agree, including a post-mortem study 
that did not find a relationship between seizure frequency and hip-
pocampal neuronal loss (Thom et al., 2005). In contrast, a recent 
study demonstrated that MTLE patients with refractory seizures 
had more significant and diffuse gray matter damage than those that 
were seizure-free or had remitting–relapsing evolution (Bilevicius 
et al., 2010). This difference maybe predominantly related to the 
heterogeneity of patients included in each study and the different 
techniques used to address the progression of atrophy.
Actually, it is important to address that MTLE is not a single 
disease (Cendes et al., 2005; Berg, 2008) but a clinical and electro-
encephalographic syndrome. The diverse prognostic and evolution 
seen on different MTLE patients may be related to different etio-
logical factors or diverse initial precipitating injuries. Studies with 
a larger number and more homogeneous individuals are necessary 
to clarify these questions.
It is most likely that seizure frequency causes further hippoc-
ampal damage and consequently volume reduction in only some 
types of epilepsies or epileptic patients. In addition, seizure types 
and duration of habitual seizures may influence neuronal damage 
differently according to the basic etiological mechanism implicit on 
each different individual. When we focus on MTLE we are surely 
evaluating epilepsies with diverse etiologies and the causes of neu-
ronal damage will certainly be different, and may not necessar-
ily be directly related to the seizures per se, but to the underlying 
mechanisms of seizure generation. Therefore, this could explain the 
fact that a phenomenologically similar seizure type (with similar 
frequency) in two different patients may cause more damage in 
one than in the other.
In this specific study, we did not aim to analyze other MRI 
features of HS, such as T2 hyperintense signal, loss of internal 
architecture, or abnormal hippocampal axis. This more subtle 
abnormalities would require a bigger number of patients to show 
significant results. Indeed, the most reliable MRI finding of HS 
is the presence of HA combined with hyperintense T2 signal. If 
we analyze any of the MRI findings isolated, HA is the most reli-
able MRI feature of HS. Hyperintense T2 signal can be present 
in some patients without atrophy, but in a very small proportion 
of patients. In addition, when we take any of these two findings 
isolated, there is a higher chance of false positives for hyperintense 
T2 signal than for atrophy (Cendes and Cascino, 2010; Labate 
et al., 2010).
it allowed the separation of two extremes of seizure control and 
to evaluate their neuroimaging evolution. We may also add the 
fact that those patients who presented only simple partial seizures 
during the follow-up and were classified here as benign, had typical 
psychic or autonomic auras of MTLE which were not disabling.
Although FMTLE is described as a benign condition, in our 
group a significant number of patients had frequent seizures. With 
this classification (benign X refractory) our main purpose was to 
clarify if refractory FMTLE had the same evolution as refractory 
SMTLE. Indeed, when we analyzed the progression of HA over time 
in the two groups (benign FMTLE and refractory FMTLE) both 
had equivalent hippocampal volume reduction. Unfortunately, 
we were not able to determine if the benign SMTLE patients had 
significant progression of HA, once the number of individuals in 
this group was too small.
It would be important to analyze these individuals in smaller 
groups concerning, for instance, sex, age of epilepsy onset or dura-
tion of epilepsy, history, and type of initial precipitating injury. 
However, the number of patients in these subgroups would be too 
small for the statistical analysis. We strongly believe that further 
studies, with a larger number of patients and more detailed MRI 
evaluation, as the measure of other mesial temporal structures 
would be interesting.
The fact that not only the FMTLE patients had a significant 
loss of hippocampal volume along the time, but also when we 
subdivided this group, the benign FMTLE individuals also had 
significant progression of HA is an important finding. We may 
speculate that the hippocampal volume reduction over time is not 
clinically significant to seizure control in FMTLE patients, since 
the group of benign individuals continued to be well controlled 
(most of them were seizure-free with or without medication) dur-
ing this period.
Our results also demonstrated that although the mean time 
between the MRIs in the FMTLE group was twice the time of the 
SMTLE group, the degree of volume reduction was not different 
between the two groups. If the progression of HA was similar in 
both groups, we would expect to find more pronounced volume 
reduction in FMTLE. We may hypothesize that this slower hip-
pocampal reduction in FMTLE happened because of the difference 
of refractory patients in both groups (88% of SMTLE vs 29% of 
FMTLE), although the benign FMTLE also had significant volume 
reduction. Most probably the mechanisms related to the progres-
sion of damage in these two groups, SMTLE and FMTLE, are diverse 
with an important contribution of the genetic characteristics in 
FMTLE. This is corroborated by a recent paper from our group 
emphasizing the stronger environmental influence in patients with 
MTLE without a family history that could influence the more wide-
spread brain structural abnormalities and worse IQ performance 
found in SMTLE patients (Yasuda et al., 2010).
We acknowledge that the significant difference in the interval 
of the MRIs between FMTLE and SMTLE is a possible limita-
tion of our study; however, it propitiated an interesting result. 
The difference in the interval of MRIs can be explained mainly 
because the patients with refractory seizures were on the waiting 
list for surgical treatment and it was not ethical to wait too long 
to do a second MRI before surgery. On the other hand, as the 
www.frontiersin.org February 2011 | Volume 2 | Article 5 | 5
Conz et al. Longitudinal MRI in familial MTLE
Cendes, F., Andermann, F., Gloor, P., 
Evans, A., Jones-Gotman, M., Watson, 
C., Melanson, D., Olivier, A., Peters, 
T., Lopes-Cendes, I., and Leroux, G. 
(1993). MRI volumetric measure-
ments of amygdala and hippocampus 
in temporal lobe epilepsy. Neurology 
43, 719–725.
Cendes, F., and Cascino, G. D. (2010). MRI 
signs of hippocampal sclerosis seen in 
healthy volunteers: what is the clinical 
relevance? Neurology 74, 534–535.
Cendes, F., Kahane, P., Brodie, M., and 
Andermann, F. (2005). “The mesio-
temporal lobe epilepsy syndrome,” 
in Epileptic Syndromes in Infancy, 
Childhood and Adolescence, 4th Edn, 
eds J. Roger, M. Buerau, C. Dravet, P. 
Genton, C. A. Tassinari, and P. Wolf 
(Montrouge: John Libbey Eurotext), 
555–575.
Coan, A. C., Appenzeller, S., Bonilha, L., Li, 
L. M., and Cendes, F. (2009). Seizure 
frequency and lateralization affect 
progression of atrophy in temporal 
lobe epilepsy. Neurology 73, 834–842.
Fuerst, D., Shah, J., Shah, A., and Watson, 
C. (2003). Hippocampal sclerosis is a 
progressive disorder: a longitudinal 
volumetric MRI study. Ann. Neurol. 
53, 413–416.
Gastaut, H., Gastaut, J. L., Gonçalves 
e Silva, G. E., and Fernandez Sanchez, 
G. R. (1975). Relative frequency of 
different types of epilepsy: a study 
employing the classification of the 
international league against epilepsy. 
Epilepsia 16, 457–461.
Jackson, G. D., Connely, A., Duncan, J. 
S., Grünewald, R. A., and Gadian, 
D. G. (1993). Detection of hip-
pocampal pathology in intractable 
partial epilepsy: increased sensitiv-
ity with quantitative magnetic reso-
nance T2 relaxometry. Neurology 43, 
1793–1799.
Kälviäinen, R., Salmenperä, T., Partanen, 
K., Vainio, P., Riekkinen, P., and 
references
Berg, A. T. (2008). The natural history of 
mesial temporal lobe epilepsy. Curr. 
Opin. Neurol. 21, 173–178.
Berkovic, S. F., Mcintosh, A., Howell, R. 
A., Mitchell, A., Sheffield, L. J., and 
Hopper, J. L. (1996). Familial tempo-
ral lobe epilepsy- a common disorder 
identified in twins. Ann. Neurol. 40, 
227–235.
Bernhardt, B. C., Worsley, K. J., Kim, 
H., Evans, A. C., Bernasconi, A., and 
Bernasconi, N. (2009). Longitudinal 
and cross-sectional analysis of atrophy 
in pharmacoresistant temporal lobe 
epilepsy. Neurology 72, 1747–1754.
Bilevicius, E., Yasuda, C. L., Silva, M. S., 
Guerreiro, C. A., Lopes-Cendes, I., and 
Cendes, F. (2010). Antiepileptic drug 
response in temporal lobe epilepsy: a 
clinical and MRI morphometry study. 
Neurology 75, 1695–1701.
Bonilha, L., Rorden, C., Appenzeller, S., 
Coan, A. C., Cendes, F., and Li, L. M. 
(2006). Gray matter atrophy associ-
ated with duration of temporal lobe 
epilepsy. Neuroimage 32, 1070–1079.
Briellmann, R. S., Berkovic, S. F., 
Syngeniotis, A., King, M. A., and 
Jackson, G. D. (2002). Seizure-
associated hippocampal volume loss: 
a longitudinal magnetic resonance 
study of temporal lobe epilepsy. Ann. 
Neurol. 51, 641–644.
Bruton, C. J. (1988). The Neuropathology 
of Temporal Lobe Epilepsy. New York: 
Oxford University Press.
Cascino, G. D., Jack, C. R. Jr., Parisi, J. 
E.,  Sharbrough, F. W., Hirschorn, 
K. A., Meyer, F. B., Marsh, W. R., and 
O’Brien, P. C. (1991). Magnetic reso-
nance imaging-based volume studies 
in temporal lobe epilepsy: pathological 
correlations. Ann. Neurol. 30, 31–36.
Cendes, F. (2005). Progressive hippocam-
pal and extrahippocampal atrophy in 
drug resistant epilepsy. Curr. Opin. 
Neurol. 18, 173–177.
Pitkänen, A. (1998). Recurrent sei-
zures may cause hippocampal damage 
in temporal lobe epilepsy. Neurology 
50, 1377–1382.
Kobayashi, E., D’Agostinho, M. D., Lopes-
Cendes, I., Berkovic, S. F., Li, M. L., 
Andermann, E., Andermann, F., and 
Cendes, F. (2003). Hippocampal atro-
phy and T2-weighted signal chances in 
familial mesial temporal lobe epilepsy. 
Neurology 60, 405–409.
Kobayashi, E., Li, M. L., Lopes-Cendes, 
I., and Cendes, F. (2002). Magnetic 
resonance imaging evidence of hip-
pocampal sclerosis in asymptomatic, 
first-degree relatives of patients with 
familial mesial temporal lobe epilepsy. 
Arch. Neurol. 59, 1891–1894.
Kobayashi, E., Lopes-Cendes, I., Guerreiro, 
C. A., Sousa, S. C., Guerreiro, M. M., 
and Cendes, F. (2001). Seizure out-
come and hippocampal atrophy in 
familial mesial temporal lobe epilepsy. 
Neurology 56, 166–172.
Labate, A., Gambardella, A., Aguglia, U., 
Condino, F., Ventura, P., Lanza, P., 
and Quattrone, A. (2010). Temporal 
lobe abnormalities on brain MRI 
in healthy volunteers: a prospective 
case-control study. Neurology 74, 
553–557.
Labate, A., Gambardella, A., Andermann, 
E., Aguglia, U., Cendes, F., Berkovic, S. 
F., and Andermann, F. (2011). Benign 
mesial temporal lobe epilepsy. Nat. 
Rev. Neurol. [Epub ahead of print].
Pitkänen, A., Nissinen, J., Nairismägi, J., 
Lukasiuk, K., Gröhn, O. H., Miettinen, 
R., and Kauppinen, R. (2002). 
Progression of neuronal damage 
after status epilepticus and during 
spontaneous seizures in a rat model 
of temporal lobe epilepsy. Prog. Brain 
Res. 135, 67–83.
Thom, M., Zhou, J., Martinian, L., and 
Sisodiya, S. (2005). Quantitative post-
mortem study of the hippocampus in 
chronic epilepsy: seizures do not inevi-
tably cause neuronal loss. Brain 128, 
1344–1357.
Watson, C., Jack, C. R. Jr., and Cendes, 
F. (1997). Volumetric magnetic reso-
nance imaging. Clinical applications 
and contributions to the understand-
ing of temporal lobe epilepsy. Arch. 
Neurol. 54, 1521–1531.
Yasuda, C. L., Morita, M. E., Alessio, A., 
Pereira, A. R., Balthazar, M. L., Saúde, 
A. V., Costa, A. L., Costa, A. L., Cardoso, 
T. A., Betting, L. E., Guerreiro, C. A., 
Damasceno, B. P., Lopes-Cendes, 
I., Tedeschi, H., de Oliveira, E., and 
Cendes, F. (2010). Relationship 
between environmental factors and 
gray matter atrophy in refractory 
MTLE. Neurology 74, 1062–1068.
Conflict of Interest Statement: The 
authors declare that the research was 
conducted in the absence of any com-
mercial or financial relationships that 
could be construed as a potential conflict 
of interest.
Received: 12 October 2010; accepted: 
30 January 2011; published online: 14 
February 2011.
Citation: Conz L, Morita ME, Coan AC, 
Kobayashi E, Yasuda CL, Pereira AR, 
Lopes-Cendes I and Cendes F (2011) 
Longitudinal MRI volumetric evaluation 
in patients with familial mesial temporal 
lobe epilepsy. Front. Neur. 2:5. doi: 10.3389/
fneur.2011.00005
This article was submitted to Frontiers 
in Epilepsy, a specialty of Frontiers in 
Neurology.
Copyright © 2011 Conz, Morita, Coan, 
Kobayashi, Yasuda, Pereira, Lopes-Cendes 
and Cendes. This is an open-access article 
subject to an exclusive license agreement 
between the authors and Frontiers Media 
SA, which permits unrestricted use, distri-
bution, and reproduction in any medium, 
provided the original authors and source 
are credited.
Up to now, there is important evidence on literature that epilepsy 
is a progressive disorder with variable severity. It is important to 
define in which particular group of patients it happens and what 
the specific causes of this progression are.
In summary, FMTLE patients have hippocampal volume 
reduction over time independently of seizure frequency although 
this progression of damage seems to be slower than what occurs 
in SMTLE.
